跳至主要内容
临床试验/NCT03701204
NCT03701204已完成不适用

Integrating Contingency Management Into Routine Care for Alcohol Use Disorder

DynamiCare Health4 个研究点 分布在 1 个国家目标入组 61 人开始时间: 2018年10月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
61
试验地点
4
主要终点
Percent of participants abstinent from alcohol at each monthly assessment time point (negative urine test and self-report of no use in past 30 days)

研究概览

简要总结

Randomized pilot study of a device (smartphone app) that poses non-significant risk to participants and is exempt from Investigational Device Exemption regulations [21 Code of Federal Regulations 812.2(c)

详细描述

To test the feasibility/acceptability and efficacy of a minimum viable product (MVP) of a smartphone app for patients with alcohol use disorder who are in active treatment and recovery to perform self-tracking of their recovery behavior (e.g., abstinence) and focus on their motivation to maintain their desired health behaviors (i.e., abstinence).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants in the pilot study will be 60 new intakes to Gosnold's outpatient Substance Use Disorder (SUD) program who:
  • are >18 years old;
  • meet DSM-5 criteria for current (past year) alcohol use disorder, at least moderate severity;
  • identify alcohol as the primary drug problem;
  • Currently use alcohol (past 7 days) or have been in treatment 14 days or less and used alcohol within 7 days of treatment entry;
  • have and use an Android or iOS smartphone with acceptable
  • capability;
  • are willing to participate in home testing and use of the smartphone,
  • speak and read the English language adequately to understand smartphone commands and responses and
  • are willing to be randomly assigned to receive treatment with or without the smartphone app as an added feature.

排除标准

  • Participants must not currently be suicidal or actively psychotic, by clinician judgement.

结局指标

主要结局

Percent of participants abstinent from alcohol at each monthly assessment time point (negative urine test and self-report of no use in past 30 days)

时间窗: 12-week intervention period

The pilot efficacy study will utilize alcohol abstinence at each assessment time point as the primary outcome. This is defined as a negative ethyl glucuronide urine test (witnessed) at the monthly assessment time points and self-report of no alcohol use in the past 30 days.

次要结局

  • Percent of participants abstinent from all drugs at each monthly assessment time point (negative urine test and self-report of no use in past 30 days)(12-week intervention period)
  • Longest continuous period of abstinence from alcohol and from drugs and alcohol(12-week intervention period)
  • Retention in treatment(12-week intervention period)

研究者

申办方类型
Industry
责任方
Principal Investigator
主要研究者

Eric Gastfriend

Principal Investigator

DynamiCare Health

研究点 (4)

Loading locations...

相似试验

Contingency Management for Alcohol Use Disorder | 临床试验